Literature DB >> 6502389

Intraduodenal events in cystic fibrosis.

A M Weber, C C Roy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6502389     DOI: 10.1097/00005176-198400031-00018

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  8 in total

1.  Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.

Authors:  J Zerega; S Lerner; J H Meyer
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

2.  Duodenal pH in cystic fibrosis and its relationship to fat malabsorption.

Authors:  P J Robinson; A L Smith; P D Sly
Journal:  Dig Dis Sci       Date:  1990-10       Impact factor: 3.199

3.  Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor.

Authors:  Drucy Borowitz; Barry Lubarsky; Michael Wilschanski; Anne Munck; Daniel Gelfond; Frank Bodewes; Sarah Jane Schwarzenberg
Journal:  Dig Dis Sci       Date:  2015-08-07       Impact factor: 3.199

Review 4.  Drug therapies for reducing gastric acidity in people with cystic fibrosis.

Authors:  Sze May Ng; Helen S Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-08-22

5.  Effect of misoprostol on fat malabsorption in cystic fibrosis.

Authors:  P J Robinson; P D Sly; A L Smith
Journal:  Arch Dis Child       Date:  1988-09       Impact factor: 3.791

6.  Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects.

Authors:  C A Youngberg; R R Berardi; W F Howatt; M L Hyneck; G L Amidon; J H Meyer; J B Dressman
Journal:  Dig Dis Sci       Date:  1987-05       Impact factor: 3.199

7.  Drug therapies for reducing gastric acidity in people with cystic fibrosis.

Authors:  Sze May Ng; Helen S Moore
Journal:  Cochrane Database Syst Rev       Date:  2021-04-27

8.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.